Persistent progress

The highly effective and safe mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines draw on decades of painstaking research to overcome the many hurdles for delivering, expressing, and avoiding toxicity of therapeutic mRNA. Cell editor Nicole Neuman talked with Dr. Katalin...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Conversations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462135/
https://www.ncbi.nlm.nih.gov/pubmed/34562365
http://dx.doi.org/10.1016/j.cell.2021.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462135/
https://www.ncbi.nlm.nih.gov/pubmed/34562365
http://dx.doi.org/10.1016/j.cell.2021.08.006

Ejemplares similares